Symbol="OVID"
AssetType="Common Stock"
Name="Ovid Therapeutics Inc"
Description="Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York."
CIK="1636651"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1460 BROADWAY, SUITE 15044, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="251126000"
EBITDA="-53590012"
PERatio="None"
PEGRatio="0"
BookValue="1.716"
DividendPerShare="0"
DividendYield="0"
EPS="-0.71"
RevenuePerShareTTM="0.002"
ProfitMargin="0"
OperatingMarginTTM="-438.5"
ReturnOnAssetsTTM="-0.203"
ReturnOnEquityTTM="-0.36"
RevenueTTM="123540"
GrossProfitTTM="1502700"
DilutedEPSTTM="-0.71"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.954"
AnalystTargetPrice="5.67"
TrailingPE="-"
ForwardPE="1.792"
PriceToSalesRatioTTM="87.09"
PriceToBookRatio="0.903"
EVToRevenue="4.56"
EVToEBITDA="-0.0966"
Beta="1.072"
num_52WeekHigh="3.98"
num_52WeekLow="1.405"
num_50DayMovingAverage="3.525"
num_200DayMovingAverage="2.598"
SharesOutstanding="70521000"
DividendDate="None"
ExDividendDate="None"
symbol="OVID"
open="3.53"
high="3.60"
low="3.53"
price="3.59"
volume="78733.00"
latest_trading_day="2023-07-31"
previous_close="3.52"
change="0.07"
change_percent="1.9886%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="5"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="95"
Volume_recent_avg="217740"
Change_recent_avg="0.02"
Delta_recent_avg="0.19"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="0.7"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="95"
Aroon_momentum_negative="5"
image_negative_thumbnail_id_1="1089"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0122.jpeg"
image_negative_thumbnail_id_2="170"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0006.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="597"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_positive_thumbnail_id_1="674"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_positive_thumbnail_id_2="698"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0010.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
